Abstract: The present disclosure relates to a modified epoxy resin having a weight average molecular weight of 5,000 to 25,000 and a polydispersity index of 5.0 to 20.0, and comprising (1) an epoxy-derived unit and (2) a modifier-derived unit, a preparation method thereof, a composition comprising the same, and uses thereof. When the epoxy composition comprising the modified epoxy resin according to the present disclosure is cured, the epoxy composition has a lowered coefficient of thermal expansion (CTE), i.e., improved thermal expansion properties, due to curing-induced phase separation (morphological properties) into an epoxy region and an acrylic region. The modified epoxy of the present disclosure and the epoxy composition comprising the same are suitable as adhesives for semiconductor packaging.

Abstract: Disclosed herein is a program conversion apparatus, which converts a first program to which homomorphic encryption is not applied into a second program to which the homomorphic encryption is applied, including a memory, which stores a first library for configuring the first program and a second library for configuring the second program, and a processor configured to convert the first program into the second program through conversion between operations provided by the first and second libraries.

Abstract: A transparent display device comprises: a first substrate including a display area and first to fourth bezel areas surrounding the display area, wherein the display area includes a plurality of pixel regions each including an emitting portion and a transparent portion; a second substrate facing the first substrate; a transparent dam between the first and second substrates and in the first to fourth bezel areas; a first pad electrode on the first substrate and in the first bezel area; and a first color filter pattern on the second substrate and in the first bezel area.

Abstract: There is provide a method for manufacturing analytical semiconductor samples by using an apparatus for manufacturing analytical semiconductor samples, which minimizes a feedback time by manufacturing a viewing surface that is environment-friendly and has a large area. The method comprising mounting the analytical semiconductor samples to a holder; discharging deionized (DI) water to an upper surface of a polishing plate through a DI water nozzle; grinding the analytical semiconductor samples with the upper surface of the polishing plat; determining whether a desired viewing surface of the analytical semiconductor samples has been acquired after the grinding of the analytical semiconductor samples; and transferring the analytical semiconductor samples to analyze the viewing surface of the ground analytical semiconductor samples based on a determination that the desired viewing surface of the analytical semiconductor samples has been acquired.

Abstract: One aspect of the present invention provides a compound in which a functional group capable of binding to a globulin Fc region or a physiologically active polypeptide is introduced at one end of a non-peptidic polymer and a functional group capable of a click reaction is introduced at the other end; a polypeptide conjugate in which a physiologically active polypeptide binds to one end of the compound; a physiologically active polypeptide conjugate in which a physiologically active polypeptide and an immunoglobulin Fc region bind to both ends thereof by using the compound as a linker; and methods for preparing the same compound, polypeptide conjugate, and physiologically active polypeptide conjugate.

Abstract: The present invention relates to a method and device for diagnosing a defect of a collaborative robot, the method comprising the steps in which: an electronic device generates a sensing data structure for managing sensing data collected from at least one collaborative robot; the electronic device generates an operation data structure for managing operation data associated with the operation of the collaborate robot; the electronic device generates a malfunction data structure for managing malfunction data of a point in which the severity of the operation equals to or is higher than a threshold; and the electronic device stores data collected from the at least one collaborative robot in accordance with the structures. Application to other embodiments is also possible.

Abstract: A method for identifying mild cognitive impairment by at least one processor of an apparatus according to some embodiments of the present disclosure is disclosed. the method comprises performing a task of acquiring digital biomarker data for identifying mild cognitive impairment of a user of a user terminal; performing a preliminary task to allow the user to check the task before performing the task; and acquiring gaze information of the user in conjunction with performing the task and the preliminary task; wherein the gaze information is used when determining displayed information in the preliminary task, and used when identifying mild cognitive impairment of the user in the task.

Abstract: A use of a fusion protein of a therapeutic enzyme and an immunoglobulin Fe region is disclosed. The fusion protein is represented by the following chemical formula 1. The fusion protein shows protective effects on peripheral sensory nerves and exhibits an extended duration in the body. Thus, the fusion protein or a composition containing the fusion protein can be used in the prevention or improvement of neuropathy.

Abstract: Disclosed is a method of identifying, by at least one processor of a device, a cognitive function state of a user. The method may include inputting user information, at least one voice data, and speech time information related to the at least one voice data to a cognitive function state identification model, and identifying a cognitive function state of the user based on first output data that is output by the cognitive function state identification model.

Abstract: Disclosed is a method of identifying, by at least one processor of a device, a cognitive function state of a user. The method may include inputting user information, at least one voice data, and speech time information related to the at least one voice data to a cognitive function state identification model, and identifying a cognitive function state of the user based on first output data that is output by the cognitive function state identification model.

Abstract: Disclosed is a method of identifying dementia by at least one processor of a device. The method may include obtaining content analysis information and voice activity analysis information by using a plurality of first voice data and second voice data which have been obtained by performing a plurality of tasks in a user terminal, and identifying dementia by inputting the content analysis information and the voice activity analysis information to a dementia identification model.

Abstract: One aspect of the present invention provides a compound in which a functional group capable of binding to a globulin Fc region or a physiologically active polypeptide is introduced at one end of a non-peptidic polymer and a functional group capable of a click reaction is introduced at the other end; a polypeptide conjugate in which a physiologically active polypeptide binds to one end of the compound; a physiologically active polypeptide conjugate in which a physiologically active polypeptide and an immunoglobulin Fc region bind to both ends thereof by using the compound as a linker; and methods for preparing the same compound, polypeptide conjugate, and physiologically active polypeptide conjugate.

Abstract: Provided are a protein conjugate in which a physiologically active polypeptide is linked to a biocompatible material via a non-peptidyl polymer-coupled fatty acid derivative compound serving as a linker, exhibiting an increased duration of physiological activity compared to natural forms and a preparation method therefor. Since an increase in serum half-life of the physiologically active polypeptide of the protein conjugate, in which the biocompatible material, the non-peptidyl polymer-coupled fatty acid derivative compound, and the physiologically active polypeptide are linked, is proved, the protein conjugate may be widely used in the field of protein drugs.

Abstract: The present disclosure relates to a hydrogenated petroleum resin and a rubber composition including the same. The hydrogenated petroleum resin according to the present disclosure not only improves the viscoelastic properties of rubber containing the same, but also has excellent compatibility with rubber, thereby improving the overall physical properties of the rubber. Thus, rubber molded articles manufactured from the rubber composition containing the hydrogenated petroleum resin, for example, tires, have improved grip strength (wet/dry) and reduce an increase in rolling resistance due to the improvement in grip force to simultaneously satisfy two properties of grip force and rolling resistance required as a tire, thereby manufacturing a low-fuel consumption and high-performance tire.

Abstract: Provided are a protein conjugate in which a physiologically active polypeptide is linked to a biocompatible material via a non-peptidyl polymer-coupled fatty acid derivative compound serving as a linker, exhibiting an increased duration of physiological activity compared to natural forms and a preparation method therefor. Since an increase in serum half-life of the physiologically active polypeptide of the protein conjugate, in which the biocompatible material, the non-peptidyl polymer-coupled fatty acid derivative compound, and the physiologically active polypeptide are linked, is proved, the protein conjugate may be widely used in the field of protein drugs.

Abstract: Provided are a protein conjugate in which a physiologically active polypeptide is linked to a biocompatible material via a non-peptidyl polymer-coupled fatty acid derivative compound serving as a linker, exhibiting an increased duration of physiological activity compared to natural forms and a preparation method therefor. Since an increase in serum half-life of the physiologically active polypeptide of the protein conjugate, in which the biocompatible material, the non-peptidyl polymer-coupled fatty acid derivative compound, and the physiologically active polypeptide are linked, is proved, the protein conjugate may be widely used in the field of protein drugs.